Status:
COMPLETED
Evaluation of the Predictive Role of Choline PET/CT on the Survival of Patients Affected by Prostate Cancer.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
the increase in the serum PSA (prostate specific antigen) value following radical treatment commonly involves subsequent treatment which, in the absence of morphological evidence of disease recovery, ...
Eligibility Criteria
Inclusion
- adult patients suffering from prostate cancer who have undergone choline PET/TC
Exclusion
- patients \< 18 years
Key Trial Info
Start Date :
August 8 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 23 2017
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT06158178
Start Date
August 8 2017
End Date
November 23 2017
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italia, Italy